These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21407000)

  • 41. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey.
    Victorri-Vigneau C; Dailly E; Veyrac G; Jolliet P
    Br J Clin Pharmacol; 2007 Aug; 64(2):198-209. PubMed ID: 17324242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zolpidem abuse and dependency in an elderly patient with major depressive disorder: a case report.
    Pourshams M; Malakouti SK
    Daru; 2014 Jul; 22(1):54. PubMed ID: 25012623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Abuse of pregabalin exists--but it's uncertain how often].
    Lakartidningen; 2011 Aug 10-23; 108(32-33):1501. PubMed ID: 21922943
    [No Abstract]   [Full Text] [Related]  

  • 44. Circadian dysregulation, zolpidem dependence, and withdrawal seizure in a resident physician performing shift work.
    Keuroghlian AS; Barry AS; Weiss RD
    Am J Addict; 2012; 21(6):576-7. PubMed ID: 23082842
    [No Abstract]   [Full Text] [Related]  

  • 45. Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome.
    Di Nicola M; Martinotti G; Tedeschi D; Frustaci A; Mazza M; Sarchiapone M; Pozzi G; Bria P; Janiri L
    Hum Psychopharmacol; 2010 Apr; 25(3):268-75. PubMed ID: 20373479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gabapentin and pregabalin: abuse and addiction.
    Prescrire Int; 2012 Jun; 21(128):152-4. PubMed ID: 22822593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zolpidem dependence in a patient with former polysubstance abuse.
    Bottlender R; Schütz C; Möller HJ; Soyka M
    Pharmacopsychiatry; 1997 May; 30(3):108. PubMed ID: 9211573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Benzodiazepines to people with substance abuse problems?].
    Waal H; Bramness JG
    Tidsskr Nor Laegeforen; 2010 Mar; 130(6):610-2. PubMed ID: 20349006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pregabalin for alcohol dependence: a critical review of the literature.
    Guglielmo R; Martinotti G; Clerici M; Janiri L
    Adv Ther; 2012 Nov; 29(11):947-57. PubMed ID: 23132700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of pregabalin in the treatment of alcohol and benzodiazepine dependence.
    Oulis P; Konstantakopoulos G
    Expert Opin Investig Drugs; 2012 Jul; 21(7):1019-29. PubMed ID: 22568872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial.
    Martinotti G; Di Nicola M; Tedeschi D; Andreoli S; Reina D; Pomponi M; Mazza M; Romanelli R; Moroni N; De Filippis R; Di Giannantonio M; Pozzi G; Bria P; Janiri L
    J Psychopharmacol; 2010 Sep; 24(9):1367-74. PubMed ID: 19346279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soyka M, Bottlender R, Möller H-J; Epidemiological evidence for a low abuse potential of zolpidem; Pharmacopsychiatry 2000, 33: 138 - 141.
    Engfer A
    Pharmacopsychiatry; 2002 Mar; 35(2):81; author reply 81-2. PubMed ID: 11951152
    [No Abstract]   [Full Text] [Related]  

  • 53. Seizure after withdrawal from supratherapeutic doses of zolpidem tartrate, a selective omega I benzodiazepine receptor agonist.
    Gilbert DL; Staats PS
    J Pain Symptom Manage; 1997 Aug; 14(2):118-20. PubMed ID: 9262041
    [No Abstract]   [Full Text] [Related]  

  • 54. Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects.
    Cubała WJ; Landowski J; Wichowicz HM
    Br J Clin Pharmacol; 2008 Mar; 65(3):444-5. PubMed ID: 17875189
    [No Abstract]   [Full Text] [Related]  

  • 55. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial.
    Martinotti G; di Nicola M; Frustaci A; Romanelli R; Tedeschi D; Guglielmo R; Guerriero L; Bruschi A; De Filippis R; Pozzi G; Di Giannantonio M; Bria P; Janiri L
    Addiction; 2010 Feb; 105(2):288-99. PubMed ID: 20078487
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Zolpidem dependence in a geriatric patient: a case report.
    Spyridi S; Diakogiannis I; Nimatoudis J; Iacovides A; Kaprinis G
    J Am Geriatr Soc; 2009 Oct; 57(10):1962-3. PubMed ID: 19807814
    [No Abstract]   [Full Text] [Related]  

  • 57. [Abuse, tolerance and dependence of zolpidem: three case reports].
    Correas Lauffer J; Braquehais Conesa D; Barbudo Del Cura E; Ochoa Mangada E
    Actas Esp Psiquiatr; 2002; 30(4):259-62. PubMed ID: 12217277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [High-dose zolpidem dependence].
    Hoch HJ; Gehring C
    MMW Fortschr Med; 2013 May; 155(8):66-7. PubMed ID: 24437143
    [No Abstract]   [Full Text] [Related]  

  • 59. Zolpidem dependence. Zolpidem dependence is frequent, and should be discussed with patients.
    Prescrire Int; 2008 Jun; 17(95):114. PubMed ID: 18634166
    [No Abstract]   [Full Text] [Related]  

  • 60. Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons.
    Weerts EM; Griffiths RR
    Behav Pharmacol; 1998 May; 9(3):285-97. PubMed ID: 9832941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.